Competing Paradigms in Alzheimer’s Research: Are We Closer to a Cure?
Alzheimer’s disease has been studied for over 100 years but the underlying cause of this devastating disease has remained unclear. However, the last several years have seen the emergence of new and surprising findings about the disease’s possible origins that are challenging the longstanding models guiding current therapeutic strategies. Join us for our 30th Annual Research Meeting where our panel of experts will discuss how old and emerging paradigms are driving the development of a new generation of drugs to treat, and possibly prevent, Alzheimer’s disease.
Monday, October 23, 2017
The Times Center
242 West 41st Street
(Between 7th and 8th Avenues)
Check in: 5:30 p.m.
Program: 6:00 p.m.
Reception: 7:30 p.m.
Dr. Max Gomez, CBS 2 Medical Reporter
Peter Davies, PhD, Director of the Litwin-Zucker Center for Alzheimer’s Disease & Memory Disorders, The Feinstein Institute for Medical Research; Professor of Pathology and Neuroscience, Hofstra Northwell School of Medicine
Samuel Gandy, MD, PhD, Mount Sinai Professor of Alzheimer’s Disease Research, Professor of Neurology and Psychiatry; Associate Director of the Mount Sinai Alzheimer’s Disease Resarch Center
Robert D. Moir, PhD, Assistant Professor of Neurology, Harvard Medical School; Assistant Professor of Neurology, Massachusetts General Hospital Neurology Research
This event is open to the public and free of charge.
The Annual Meeting is generously supported by Bill and Jane Brachfeld.